The efficacy of immune checkpoint inhibitors (ICIs) in colon cancer (CC) is limited by the tolerogenic immune landscape of both the tumor and the inte…

The tough new policy was introduced to curb submissions, but drew criticism from researchers.

Immune-remodeling mRNAs delivered in lipid nanoparticles boost antitumor immunity.

Chronic inflammation increases the risk of colon cancer. This inflammation drives epigenetic changes in the nucleus of stem cells that promote tumour formation.

The School will be a 4-day (23-26 June 2026) Theory&Computation course in a splendid Swedish inland Resort (2 hours away from Stockholm - our bus will

PhD Project - Evolution and adaptation of improved adenoviral platforms for the treatment of glioblastoma at Cardiff University, listed on FindAPhD.com

To mark International Women’s Day, Nature asked winners of its awards programmes to nominate a colleague who brings out the best in them.

; Presenters F. Apr 29 2026; 4193475;

Onkar et al. discuss the current landscape of therapeutic cancer vaccines in the context of recent clinical trials, with a special focus on neoantigen vaccines. They also highlight challenges and scop...

Ruslan Medzhitov shares his thoughts on the balance between generating data and developing theories in immunology, with a focus on exploring the rules that govern complex systems.

Researchers are targeting dormant tumour cells that might explain why some cancers reappear long after successful treatment.

CCR7+ dendritic cells (DCs) are pivotal for antitumor immunity. Zitti, Duval et al. find that intratumoral CCR7+ DCs form perivascular hubs dependent on CCL19-CCR7 signaling. Regulatory T cells (Tregs...

Tumour-reactive CD8+ T cells are enriched in functional clusters with tumour cells and/or antigen-presenting cells and can be isolated and expanded from clinical samples.

This Review by Imianowski et al. outlines the various contributions that regulatory T cells, present in the tumour microenvironment, make towards tumour progression and highlight the ways in which they represent attractive next-generation immunotherapeutic targets.

Triple-negative breast cancer (TNBC) is characterized by high risks of relapse or metastatic disease. Mattavelli et al. identify a chemokine axis that recruits immunosuppressive monocytes to tumor-dra...

This Consensus Statement clarifies the existing subset-based nomenclature for T cells. Furthermore, it proposes an alternative modular nomenclature that is designed to be brief and flexible and to avo...

Tu et al. present a systematic analysis of the tumor microenvironment across 14,837 breast cancers, identifying distinct cellular patterns that predict disease-specific survival independently of genomic and intrinsic subtypes. Characterizing microenvironment composition may provide critical prognostic markers that can complement current molecular classification for treatment selection and preventing recurrence.

Hurra! 🎉🎉🎉 Nu har vi fattat beslut om att finansiera forskning för mer än en miljard! Tack vare alla gåvor från givare förflyttar vi forskningsfronten på en mängd områden och särskilt inom tidig upptä...

PhD Project - Developing precision guided, viral based therapies using machine learning approaches at Cardiff University, listed on FindAPhD.com

Nature Biomedical Engineering - This Review explores strategies for targeting and tracking RNA-LNP drugs, monitoring their in vivo behaviour, enhancing tissue-specific delivery, and using synthetic...